Therapy evaluation of laryngeal carcinomas by tyrosine-PET

Head and Neck

Volumn 25, Issue 8, 2003, Pages 634-644

  De Boer, Jurjan R ^a   Pruim, Jan ^a   Burlage, Fred ^a   Krikke, Allard ^a   Tiebosch, Anton T M G ^a   Albers, Frans W J ^a   Vaalburg, Willem ^a   Van der Laan, Bernard F A M ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

L 1 11C tyrosine (TYR); Laryngeal carcinoma; Positron emission tomography (PET); Protein synthesis rate (PSR); Therapy evaluation

Indexed keywords

CARBON 11; CARBON DIOXIDE; TYROSINE;

ADULT; AGED; ARTICLE; BIOPSY; BLOOD SAMPLING; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; FEMALE; HEAD AND NECK CARCINOMA; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ISOTOPE LABELING; LARYNGOSCOPY; LARYNX CARCINOMA; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; CARBON RADIOISOTOPES; CARCINOMA, SQUAMOUS CELL; FEASIBILITY STUDIES; FEMALE; HUMANS; LARYNGEAL NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM, RESIDUAL; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED; TYROSINE;

EID: 0042344709     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/hed.10273     Document Type: Article

References (38)

1. Bronstein AD, Nyberg DA, Schwartz AN, Schuman WP, Griffin BR. Soft tissue changes after head and neck radiation: CT findings. AJNR 1989;10:171-175.
2. Million RR, Cassisi NJ, Mancuso AA. Larynx. In: Million RR, Cassisi NJ, editors. Management of head and neck cancer: a multidisciplinary approach. 2nd ed. Philadelphia: Lippincott; 1994. p 461-467.
3. Gussack GS, Hudgins PA. Imaging modalities in recurrent head and neck tumors. Laryngoscope 1991;101:119-124.
4. McGuirt WF, Greven KM, Keyes JW, et al. Laryngeal radionecrosis versus recurrent cancer: a clinical approach. Ann Otol Rhinol Laryngol 1998;107:293-296.
5. Fu KK, Woodhouse RJ, Quivey JM, et al. The significance of laryngeal edema following radiotherapy of carcinoma of the vocal cord. Cancer 1982;49:655-658.
6. Vianni L, Stell PM, Dalby JE. Recurrence after radiotherapy for glottic carcinoma. Cancer 1991;67:577-584.
7. Warburg O. The metabolism of tumors. New York: Richard R. Smith; 1931. p 129-169.
8. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med 2000;30:150-185.
9. Bailet JW, Abemayor E, Jabour BA, Hawkins RA, Ho C, Ward PH. Positron emission tomography: a new, precise imaging modality for detection of primary head and neck tumors and assessment of cervical adenopathy. Laryngoscope 1992;102:281-288.
10. Rege S, Maass A, Chaiken L, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 1994;73:3047-3058.
11. Strauss LG. Fluorine-18 deoxyglucose and false-positive results: a major problem in the diagnostics of oncological patients. Eur J Nucl Med 1996;23:1409-1415.
12. Lapela M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18] fluoro-2-deoxy-D-glucose. Radiology 1995;197:205-211.
13. Kubota K, Matsuzawa T, Fujiwara T, et al. Differential diagnosis of AH109A tumor and inflammation by radioscintigraphy with L-[methyl-11C]]methionine. Jpn J Cancer Res 1989;80:778-782.
14. Jager PL, Vaalburg W, Pruim J, de Vries EG, Langen KJ, Piers DA. Radiolabeled amino acids: basic aspects and clinical applications in oncology. J Nucl Med 2001;42:432-445.
15. Ishiwata K, Kubota K, Murakami M, Kubota R, Senda M. A comparative study on protein incorporation of L-[methyl-3H]methionine, L-[1-14C]leucine and L-2-[18F] fluorotyrosine in tumor bearing mice. Nucl Med Biol 1993; 20:895-899.
16. Willemsen AT, van-Waarde A, Paans AM, et al. In vivo protein synthesis rate determination in primary or recurrent brain tumors using L-[1-11C]-tyrosine and PET. J Nucl Med 1995;36:411-419.
17. Pruim J, Willemsen AT, Molenaar WM, et al. Brain tumors: L-[1-C-11]tyrosine PET for visualization and quantification of protein synthesis rate. Radiology 1995;197:221-226.
18. Kole AC, Pruim J, Nieweg OE, et al. PET with L-[1-carbon-11)-tyrosine to visualize tumors and measure protein synthesis rates. J Nucl Med 1997;38:191-195.
19. Ginkel van RJ, Kole AC, Nieweg OE, et al. L-[1-11C]tyrosine PET to evaluate response to hyperthermic isolated limb perfusion for locally advanced soft-tissue sarcoma and skin cancer. J Nucl Med 1999;40:262-267.
20. Boer de JR, Laan van der BFAM, Pruim J, et al. C-11-Tyrosine PET for visualization and protein synthesis rate assessment of laryngeal and hypopharyngeal carcinomas. Eur J Nucl Med 2002;29:1182-1187.
21. International Union Against Cancer (UICC). Primary tumor, regional nodes and metastasis (TNM) atlas classification of malignant tumors. 3rd ed. Berlin-Heidelberg: Springer-Verlag; 1997.
22. Thorell JO, Stone-Elander;S, Elander N. Use of a microwave cavity to reduce reaction times in radiolabelling with [11-C]cyanide. J Labelled Compounds Radiophar 1992;31:207-217.
23. Kole AC, Nieweg OE, Pruim J, Paans AMJ. Standardized uptake values and quantification of metabolism for breast cancer imaging with FDG and L-[1-11C]-tyrosine PET. J Nucl Med 1997;38:692-696.
24. Anzai Y, Carroll WR, Quint DJ, et al. Recurrence of head and neck cancer after surgery or irradiation: prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnosis. Radiology 1996;200:135-141.
25. Greven KM, Williams DW, Keyes JW, et al. Positron Emission Tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 1994;74:1355-1359.
26. Lapela M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18] fluoro-2-deoxy-D-glucose. Radiology 1995;197:205-211.
27. Hanasono MH, Kunda LD, Segall, GM, et al. Uses and limitations of FDG positron emission tomography in patients with head and neck cancer. Laryngoscope 1999;109:880-885.
28. Lapela M, Eigtved A, Jyrkkio S, et al. Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer 2000;36:858-867.
29. Wong WL, Chevretton EB, McGurk M, et al. A prospective study of PET-FDG imaging for the assessment of head and neck squamous cell carcinoma. Clin Otolaryngol 1997;22:209-214.
30. Fischbein NJ, Aassar OS, Caputo GR, Kaplan MJ. Clinical utility of positron emission tomography with 18-F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma in head and neck. AJNR 1998;19:1189-1196.
31. Kubota R, Yamada S, Kubota K, Ishiwata K, Tamahashi N, Ido T. Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med 1992;33:1972-1980.
32. Lindholm P, Leskinen-Kallio S, Grenman R, Lehikoinen P. Evaluation of response to radiotherapy in head and neck cancer by positron emission tomography and 11C-methionine. Int J Radiat Oncol Biol Phys 1995;32:787-794.
33. Nuutinen J, Jyrkkiö S, Lehikoinen P, Lindholm P, Minn H. Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography. Radiother Oncol 1999;52:225-232.
34. Ishiwata K, Kubota K, Murakami M, et al. Re-evaluation of amino acid PET studies: can the protein synthesis rates in brain and tumor tissue be measured in vivo? J Nucl Med 1993;34:1936-1943.
35. Bolster JM, Vaalburg W, Paans AM, et al. Carbon-11 labelled tyrosine to study tumor metabolism by positron emission tomography (PET). Eur J Nucl Med 1986;12:321-324.
36. Kole AC, Plaat BE, Hoekstra HJ, Vaalburg W, Molenaar WM. FDG and L-[1-11C]-tyrosine imaging of soft-tissue tumors before and after therapy. J Nucl Med 1999;40:381-386.
37. Reinhardt MJ, Kubota K, Yamada S, et al. Assessment of cancer recurrence in residual tumors after fractionated radiotherapy: a comparison of fluorodeoxyglucose, L-methionine and thymidine. J Nucl Med 1997;38:280-287
38. Rege SD, Chaiken L, Hoh CK, et al. Change induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET. Radiology 1993;189:807-812.